Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Price, Quote, News and Overview

EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR

115.3  +0.8 (+0.7%)

BIM.PA Quote, Performance and Key Statistics

BIOMERIEUX

EPA:BIM (3/7/2025, 7:00:00 PM)

115.3

+0.8 (+0.7%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High120
52 Week Low88.25
Market Cap13.65B
Shares118.36M
Float42.66M
Yearly Dividend0.85
Dividend Yield0.74%
PE33.32
Fwd PE25.05
Earnings (Next)09-03 2025-09-03
IPO06-07 2004-06-07


BIM.PA short term performance overview.The bars show the price performance of BIM.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

BIM.PA long term performance overview.The bars show the price performance of BIM.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15

The current stock price of BIM.PA is 115.3 EUR. In the past month the price increased by 1.77%. In the past year, price increased by 16.04%.

BIOMERIEUX / BIM Daily stock chart

BIM.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 29.15 217.38B
IUI1.DE INTUITIVE SURGICAL INC 69.31 166.86B
BSX.DE BOSTON SCIENTIFIC CORP 39.18 133.56B
1BSX.MI BOSTON SCIENTIFIC CORP 39.52 133.38B
1MDT.MI MEDTRONIC PLC 17.48 113.17B
2M6.DE MEDTRONIC PLC 17.56 110.81B
1SHL.MI SIEMENS HEALTHINEERS AG 25.27 60.49B
BOX.DE BECTON DICKINSON AND CO 16.4 60.33B
SHL.DE SIEMENS HEALTHINEERS AG 23.49 59.08B
1EW.MI EDWARDS LIFESCIENCES CORP 26.07 39.21B
EWL.DE EDWARDS LIFESCIENCES CORP 26.65 37.76B
DC4.DE DEXCOM INC 48.5 28.81B

About BIM.PA

Company Profile

BIM logo image bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 14,651 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Company Info

BIOMERIEUX

376, chemin de l'Orme

Craponne AUVERGNE-RHONE-ALPES FR

Employees: 13696

Company Website: https://www.biomerieux.fr/

Investor Relations: https://www.biomerieux.com/en/finance

Phone: 33478872000

BIOMERIEUX / BIM.PA FAQ

What is the stock price of BIOMERIEUX today?

The current stock price of BIM.PA is 115.3 EUR. The price increased by 0.7% in the last trading session.


What is the ticker symbol for BIOMERIEUX stock?

The exchange symbol of BIOMERIEUX is BIM and it is listed on the Euronext Paris - Matif exchange.


On which exchange is BIM.PA stock listed?

BIM.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for BIOMERIEUX stock?

19 analysts have analysed BIM.PA and the average price target is 126.23 EUR. This implies a price increase of 9.48% is expected in the next year compared to the current price of 115.3. Check the BIOMERIEUX stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOMERIEUX worth?

BIOMERIEUX (BIM.PA) has a market capitalization of 13.65B EUR. This makes BIM.PA a Large Cap stock.


How many employees does BIOMERIEUX have?

BIOMERIEUX (BIM.PA) currently has 13696 employees.


What are the support and resistance levels for BIOMERIEUX (BIM.PA) stock?

BIOMERIEUX (BIM.PA) has a support level at 115.1 and a resistance level at 115.32. Check the full technical report for a detailed analysis of BIM.PA support and resistance levels.


Is BIOMERIEUX (BIM.PA) expected to grow?

The Revenue of BIOMERIEUX (BIM.PA) is expected to grow by 7.52% in the next year. Check the estimates tab for more information on the BIM.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOMERIEUX (BIM.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOMERIEUX (BIM.PA) stock pay dividends?

BIOMERIEUX (BIM.PA) has a dividend yield of 0.74%. The yearly dividend amount is currently 0.85. Check the full fundamental report for a detailed analysis of BIM.PA dividend history, reliability and sustainability.


When does BIOMERIEUX (BIM.PA) report earnings?

BIOMERIEUX (BIM.PA) will report earnings on 2025-09-03.


What is the Price/Earnings (PE) ratio of BIOMERIEUX (BIM.PA)?

The PE ratio for BIOMERIEUX (BIM.PA) is 33.32. This is based on the reported non-GAAP earnings per share of 3.46 and the current share price of 115.3 EUR. Check the full fundamental report for a full analysis of the valuation metrics for BIM.PA.


BIM.PA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to BIM.PA. When comparing the yearly performance of all stocks, BIM.PA is one of the better performing stocks in the market, outperforming 87.28% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BIM.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA. While BIM.PA has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BIM.PA Financial Highlights

Over the last trailing twelve months BIM.PA reported a non-GAAP Earnings per Share(EPS) of 3.46. The EPS increased by 6.54% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.81%
ROA 7.73%
ROE 10.63%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%33.49%
Sales Q2Q%7.45%
EPS 1Y (TTM)6.54%
Revenue 1Y (TTM)2.85%

BIM.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 77% to BIM.PA. The Buy consensus is the average rating of analysts ratings from 19 analysts.

For the next year, analysts expect an EPS growth of 11.38% and a revenue growth 7.52% for BIM.PA


Ownership
Inst Owners20.96%
Ins Owners0.05%
Short Float %N/A
Short RatioN/A
Analysts
Analysts76.84
Price Target126.23 (9.48%)
EPS Next Y11.38%
Revenue Next Year7.52%